IndraLab

Statements

NPPA binds USP36. 11 / 11
| 11
sparser
"When the amount of drug diffused per cm 2 of membrane was plotted against square root of time (Higuchi diffusion kinetics), there was a linear relationship with high correlation coefficient (0.9687 to[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
25089511
sparser
"Because outliers are expected to occur on occasion with in vitro drug release testing (for example, due to an air bubble between the product sample and the membrane), a nonparametric statistical techn[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
25089511
sparser
"The HPLC analytical method was validated according to USP Validation of Compendial Methods ( USP36-NF31, 2013a )."
25311180
sparser
"The extraction solvent (acetonitrile, methanol and water in the ratio of 45:5:50) was almost the same as recommended in USP (acetonitrile and water in the ratio of 50:50) for the assay of estradiol ( [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
25311180
sparser
"The current method was adapted from literature ( Parry et al., 1992 ), and was validated per USP guideline ( USP36-NF31, 2013 )."
26241753
sparser
"These values are in compliance with the USP acceptance criteria (85–120%) for the assay of estradiol TDDS ( USP36-NF31, 2013b )."
25311180
sparser
"This was carried out as per the procedure described in USP ( USP36-NF31, 2013a )."
25089511
sparser
"Immersion cell model A (exposed area of 2 cm 2 ; Agilent Technologies, USA) was used with USP apparatus 2 to determine the in vitro release of acyclovir from DOE formulations as per the procedure desc[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
25089511
sparser
"The cumulative amount of drug dissolved per cm 2 of exposed membrane area was plotted against square root of time (Higuchi plot) to determine the in vitro release rate (slope of Higuchi plot) of acycl[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
25089511
sparser
"The HPLC analytical method was validated according to USP Validation of Compendial Methods ( USP36-NF31, 2013c )."
25089511
sparser
"When tested for drug content uniformity, all the formulations including Zovirax ® complied with USP specifications ( USP36-NF31, 2013c )."
25089511